T1	Participants 82 117	patients with interstitial cystitis
T2	Participants 435 451	patients with IC
T3	Participants 651 662	participant
T4	Participants 1210 1253	Eighteen (18) patients completed the trial.
T5	Participants 1700 1716	patients with IC